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West Nile virus (WNV) is a member of the Flaviviridae family of vector-borne pathogens. Clinical signs of
WNV infection include neurologic symptoms, limb weakness, and encephalitis, which can result in paraly-
sis or death. We report that the WNV capsid (Cp) by itself induces rapid nuclear condensation and cell
death in tissue culture. Apoptosis is induced through the mitochondrial pathway resulting in caspase-9
activation and downstream caspase-3 activation. Capsid gene delivery into the striatum of mouse brain or
interskeletal muscle resulted in cell death and inflammation, likely through capsid-induced apoptosis in
vivo. These studies demonstrate that the capsid protein of WNV may be responsible for aspects of viral
pathogenesis through induction of the apoptotic cascade.
est Nile virus (WNV) is a member of the Flaviviridae
family, which includes St. Louis encephalitis virus, Kun-
jin virus, yellow fever virus,  Dengue virus, and Japanese
encephalitis virus (1). WNV, a single-stranded RNA virus, was
initially isolated in the West Nile region of Uganda in 1937 (1)
and has become prevalent in Africa, Asia, and Europe. Since
its introduction into the United States in summer 1999, the
sudden and rapid spread of this virus in the United States has
caused much concern. WNV has been reported in infected
mothers’ breast milk, and WNV transmission by organ trans-
plantation and transfusion has been documented. Clearly,
WNV infection is not only a regional public health problem,
but a global health issue (2). However, we lack a clear under-
standing of WNV pathogenesis, and little specific treatment
exists for WNV infection. Therefore, a clearer understanding
of WNV is necessary in order to identify new strategies to treat
or prevent this viral infection (3).
Here we report on an unexpected role for WNV capsid
(Cp) in viral-induced pathogenesis. We observed that the
WNV-Cp protein is a pathogenic protein, which drives apopto-
sis in vitro through the mitochodrial/caspase-9 pathway. We
also observed that expression of Cp protein in mouse muscle
resulted in apoptosis and inflammation of muscle cells. More
importantly, direct in vivo expression of WNV-Cp protein in
mouse brain resulted in an induction of apoptosis similar to
what is observed in natural infection. These results provide
evidence of a link between WNV-Cp protein and WNV patho-
genesis in vivo.
Materials and Methods
Cloning and Expression Analysis of WNV-Cp Gene
The cloning of a synthetic WNV-Cp gene based on the
reported NY-99 infectious strain was described earlier (4).
Western blot analysis was performed as previously described
(4). For a caspase-9–specific test, 5 µg of pcWNV-Cp-DJY or
pcWNV-CpWT was cotransfected with a dominant negative
caspase-9 (DN caspase-9) construct, and cleavage of pro-
caspase-9 protein was determined by Western blot analysis
with antihuman caspase-9 antibody (MBL, Nagoya, Japan).
DN caspase-9 (provided courtesy of Emad S. Alnmeri, Tho-
mas Jefferson University, Philadelphia, PA) has been reported
to inhibit the caspase cascade (5). The localization pattern of
capsid expression was analyzed by immunofluorescent assay
in HeLa, 293-T, RD, or SH-SY5Y cells by using anti-His tag
antibody as described (6).
Observations with Electron Microscope 
RD cells transfected with pcWNV-Cp-DJY or pcDNA3.1
plasmid DNA were processed for transmission electron micro-
scope analysis as described (7,8). Semithin (1.0-µm) sections
were stained with toluidine blue, and photographed with
Ektachrome 160T film (Eastman Kodak Co., Rochester, NY).
Ultrathin sections were stained with uranyl acetate and lead
citrate, and observed with a Philips CM-100 electron micro-
scope, operated at 60 Kv.
TUNEL Assay and Annexin V Staining
In vitro apoptosis in individual cells was determined by
terminal desoxyriboxyl-desoxyriboxyl transferase–mediated
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DVTP nick-end labeling (TUNEL) assay with the In Situ Cell
Death Assay Kit (Roche Diagnostic Corp., Indianapolis, IN)
and visualized by fluorescent microscopy. Apoptosis induction
by the expression of capsid was also determined by annexin V
staining procedure followed by fluorescence-activated cell
sorter  analysis. Cells were transfected with the WNV-Cp–
enhanced green fluorescent protein (EGFP) fusion construct or
pcDNA3.1. Forty-eight hours after transfection, the cells were
stained with phycoerythrin-conjugated annexin V. Only
EGFP-expressing cells were analyzed and the data were
acquired by using the CellQuest software package (Becton-
Dickinson, and Co., Franklin Lakes, NJ).
Mouse Muscle Injection
Female 6- to 8-week-old Balb/c mice (Charles River Lab-
oratories, Inc., Wilmington, MA) were injected in the tibialis
muscle with 100 µg of pcWNV-Cp-DJY or pcDNA3.1 in
phosphate-buffered saline (PBS) and 0.25% bupivicaine-HCl
(Sigma-Aldrich Corp., St. Louis, MO) as described (9). After
48 h, the tibialis muscle was harvested and embedded in
OCT Compound (Sakura Finetek U.S.A., Inc., Torrance,
CA). Muscle sections were prepared by cryosectioning and
stored at –20°C until assayed. For pathologic observation,
tissue sections were stained with hematoxylin/eosin (9).
DNA Injection into Mouse Brain
Balb/c mice were anaesthetized with ketamine/xylazine
(70 mg/kg of ketamine, 7 mg/kg of xylazine). Using a Hamil-
ton syringe (Hamilton Co., Reno, NV) with a 30-gauge remov-
able needle, 5 µg of pcWNV-Cp–DJY or pcDNA3.1 DNA, in
5 µL of endotoxin-free water and 0.25% of bupivicaine-HCl in
PBS was injected into the frontal cortex (striatum) with a small
animal stereotactic apparatus (Kopf Instruments, Tujunga,
CA) as described (10). The DNA was injected for 3 min; the
needle was left in the place for 1 min and then withdrawn
slowly over 1 min.
Mouse Brain Tissue Immunohistochemistry 
by Using Horseradish Peroxidase (HRP)
Twenty four to 48 h postinjection, mice were deeply anes-
thetized and perfused transcardially with 0.1 M PBS (pH 7.2),
then with 4% paraformaldehyde (PFA) in PBS. The brains
were postfixed in 4% PFA for 18 h at 4°C and cryoprotected
in 30% sucrose for 48 h at 4°C, then frozen and mounted for
cryostat sectioning. Sections (25 µm) were serially cut in the
coronal plane. The tissue sections were treated with anti-
Histag antibody with appropriate secondary antibody with the
counterstaining of hematoxylin. The slides were analyzed
under a fluorescent microscope for TUNEL or gene expres-
sion.
Detection of Mictochondria-Based Apoptotic Pathways
Caspase-3 (Pharmingen, San Diego, CA), caspase-8
(FADD-like interleukin-1 beta-converting enzyme) and
caspase-9–like Mch6 (MBL, Nagoya, Japan) activities were
determined according to the manufacturer’s protocol. RD cells
transfected with pcWNV-Cp–DJY or pcDNA3.1 were har-
vested and lysed at 48 h postinjection. The cell lysates (100 µg/
100  µl protein) were incubated with specific substrate Ac-
DEVD-AMC for caspase-3, IETD-pNA for caspase-8, or
LEHD-pNA for caspase-9 for 1–2 h at 37°C. For the inhibition
test, IETD-FMK or LEHD-FMK, inhibitors for caspase-8 or -9,
respectively (MBL) were added to the reaction, along with the
substrate, according to the protocol. The activity of released
AMC or pNA was determined by spectrophotometer at 405
nm. The mitochondria transmembrane potential was measured
by using a DePsipher assay kit (R&D Systems, Minneapolis,
MN). The cells were observed under a fluorescent microscope,
and the images were acquired and analyzed in an Image-Pro
program (Media Cybernetics, Inc., Houston, TX).
Results and Discussion
WNV is a vector-borne pathogen that induces encephalitis
and death in WNV-endemic regions (11). Unfortunately, no
specific therapy exists for WNV infection (3). Furthermore,
the exact mechanisms of WNV-induced pathogenesis have not
been elucidated. To attain a better understanding of possible
mechanisms of WNV biology, we studied the role of the
capsid gene in WNV pathogenesis.
WNV-Cp Protein Induces Apoptosis in Cells In Vitro
The expression of the Cp gene was examined by in vitro
transcription/translation system as well as Western blot analy-
sis (Figure 1a-h). The cells expressing WNV-Cp, as well as
the positive control plasmid encoding the proapoptotic pro-
tein, Bax, show nuclear condensation, which is a typical fea-
ture of apoptotic cells. We carried out TUNEL assays for
apoptosis with a double-staining procedure. The WNV-Cp–
transfected HeLa cells were simultaneously stained for
TUNEL assay, which reveals nuclear condensation, and for
capsid expression with rhodamine-conjugated secondary anti-
body. The double-positive cells (Figure 2i) (Figure 2j) indi-
cate the induction of apoptosis specifically driven by the
expression of capsid.
Cells transfected with pcWNV-Cp-DJY were further
investigated by transmission electron microscopy. Examina-
tion of semithin sections (1.0 µm) stained with toluidine blue
revealed typical apoptotic cells representing approximately
5% of the total cell population in pcWNV-Cp-DJY–transfected
cells (Figure 2d, arrow) but not in control cells (Figure 2e).
These apoptotic cells usually lost their polygonal shape as well
as their contact with neighboring cells, and became round and
stained exceptionally dark. Many of the apoptotic cells also
exhibited clear vacuoles in the condensed cytoplasm. Frag-
mented, but equally condensed, apoptotic bodies were also
present. Ultrastructurally, all of the apoptotic cells showed
continuous plasma membranes, apparent aggregation of
nuclear chromatin, highly condensed cytoplasm, and nearly
intact organelles (Figure 2f). Cells transfected with pcWNV-
Cp-DJY show typical features of apoptosis.Emerging Infectious Diseases  •  Vol. 8, No. 12, December 2002 1381
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mid was used as a positive control. Experiments with annexin
V staining revealed that 22.9% of WNVCp-transfected cells
undergo phosphatidylserine dislocalization, a typical early fea-
ture of apoptosis (Figure 2o). 
Apoptosis by WNV-Cp In Vivo
We have shown, as have other researchers, that induction
of apoptosis by plasmid in vivo results in enhanced levels of
proinflammatory T-cell activation (4,9,12–14). We extended
these in vitro findings of the ability of WNV-Cp to induce apo-
ptosis to an animal model in vivo by using a direct plasmid
delivery method as described (9,14). At 24 h after plasmid
injection, TUNEL revealed positive signals (noted by dark
brown because of the HRP-DAB reaction) in pcWNV-Cp-DJY
injected mouse muscle (Figure 3a, arrows) but not in control
muscle (Figure 3b). We observed severe inflammation within
48 h in mouse muscle injected with pcWNV-Cp-DJY (Figure
3c) but not in the pcDNA3.1-injected mouse muscle (Figure
3d). These studies indicate that expression of Cp protein in
mouse muscle resulted in apoptosis and inflammation of mus-
cle cells in vivo. In this regard, induction of apoptosis and the
resulting inflammatory cell infiltration induced by WNV-Cp
expression may have an important role in viral pathogenesis.
WNV has been found in the brains (15) and cerebrospinal
fluids (16) of infected patients, where it induces cell death,
resulting in encephalitis (17–19). As no component of WNV
had been previously implicated in in vivo cell death of neuronal
tissue, we reasoned that the WNV-Cp was a possible candidate,
and we sought to investigate the effects of WNV-Cp in the
brain in vivo. We directly injected DNA into the brain because
that approach would not be complicated by vector delivery.
Mice were injected stereotactically with WNV-Cp or con-
trol plasmid DNA and euthanized 24–48 h after injection. Sec-
tions were processed from the harvested brain samples as
described in Materials and Methods. By using a monoclonal
antibody specific to the His epitope contained in the plasmid
vector, immunohistochemical analysis revealed that His-posi-
tive cells, as identified by HRP or fluorescein isothiocynate
(FITC) were found in pcWNV-Cp-DJY–injected mouse brain
(Figure 3f, h, respectively). Similar expression was absent in
the brains of mice injected with control plasmid (Figure 3e, j,
respectively). However, His-positive cells were detected in
several areas of the cerebral cortex, including the motor cortex
of the pcWNV-Cp-DJY injected mice (Figure 3f by HRP, and
3h by FITC [arrows]). Nuclear condensation, a classic feature
of apoptosis, was also observed in these sections by DAPI
staining (Figure 3i and 3m; arrows). As shown in Figure 3g by
HRP and 3l by FITC, we observed TUNEL-positive cells in
the brain sections from the pcWNV-Cp-DJY–injected mice
(Figure 3g and 3l) and not in the pcDNA3.1–injected control
mice (Figure 3n). These TUNEL-positive cells were localized
to the specific sites of injection (Figure 3l, arrow). These
results illustrate that His-expressing cells were also TUNEL-
positive, showing the direct relationship of WNV-Cp expres-
sion and in vivo apoptosis. WNV-Cp protein expression and
The induction of apoptosis by capsid expression was also
confirmed in different human cell lines such as HeLa, 293, RD,
or SH-SY5Y. All three cell lines, HeLa, 293, and RD, trans-
fected with pcWNV-Cp-DJY were TUNEL-positive (Figure
2g, 2i, and k, respectively), whereas the control transfected
cells were not (Figure 2m). Proapoptotic Bax expression plas-
Figure 1. Construction and subcellular expression of West Nile virus
(WNV)–NY1999 capsid (Cp) gene–expressing plasmid, pcWNV-Cp-
DJY: a, Genomic organization of WNV-NY1999 (10,945 bp) is outlined
based on the published (GenBank accession no. AF202541). b, Cloning
strategy for WNVCp gene–expressing plasmid, pcWNV-Cp-DJY. c, In
vitro translated and immunoprecipitated 35S-labeled WNV-Cp visualized
by SDS-PAGE. WNV-Cp–specific protein synthesis was compared to
control generated by the vector backbone pcDNA3.1 (-). d, Protein
expression by Western blot analysis, of WNV-Cp expression in HeLa
cells. Subcellular location of WNV-Cp protein, in HeLa cells transfected
with pcWNV-CpWT (e,f) or pcWNV-Cp-DJY (g,h) plasmids. 16 h post-
transfection, the cells were visualized by indirect immunofluorescence.
Typical nuclear staining was observed with the cells expressing WNV-
CpWT (e) compared to the cells expressing WNV-Cp-DJY (g). TUNEL
assay on the WNV-Cp–transfected cells, indicating nuclear condensa-
tion (i) due to expression of capsid (j).RESEARCH
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apoptosis as well as inflammation were highly reproducible in
all animals studied by injection with pcWNV-Cp-DJY plas-
mid. These data strongly suggest that the expression of the
WNV-Cp protein in the central nervous system can play a role
in neuronal cell death, and this process may be important in
the pathogenesis of WNV-induced encephalitis.
Mitochondrial-Activated apoptotic Pathway
To characterize the apoptosis pathway activated by the
WNV-Cp protein, we next examined its direct effects on the
disruption of the mitochondrial transmembrane potential in
these cells. HeLa-CD4 cells were transfected with pcWNV-
Cp-DJY or pcDNA3.1 plasmids, and the mitochondrial mem-
brane potential was measured with a DePsipher assay kit
(R&D Systems). The pcDNA3.1-transfected cells showed a
normal pattern of orange-red fluorescence (Figure 4b). In con-
trast, green fluorescence was clearly visible in the pcWNV-
Cp-DJY–transfected cells (Figure 4a, arrows). 
We examined the effects of WNV-Cp on caspase-3, -8, or -9
activity. Cell lysates from pcWNV-Cp-DJY–transfected cells
showed marked activity for caspase-3, illustrating substantial
apoptotic induction (Figure 4c). Moreover, the cell lysate har-
vested from pcWNV-Cp-DJY–transfected cells was positive for
caspase-9 activity, and this activity was inhibited by the addition
of the caspase-9-specific inhibitor, LEHD-FMK (Figure 4d). In
contrast, caspase-8 activity from these samples was not greatly
increased relative to the negative control, and little effect was
noted by the addition of the caspase-8–specific inhibitor, IETD-
FMK (data not shown). Cell lysates from pcDNA3.1 control
transfected cells show no caspase-8 (data not shown) or -9 activ-
ity (Figure 4d). These results firmly suggest that the mechanism
of WNV-Cp–induced apoptosis is through the disruption of the
mitochondrial transmembrane potential and the activation of
caspase-9, which result ultimately in activation of the caspase-3
pathway.
Mapping Apoptosis-Inducing Domain
To map the apoptosis-inducing domain, a 3′ -terminal dele-
tion mutant with deletion of 3′ -terminal 55 amino acids was
generated, and its integrity was tested by in vitro translation/
transcription (Figure 5a,b). Furthermore, to examine whether
the specific 3′ -terminal region is a determinant for the
observed apoptosis, plasmids were transfected into RD cells,
and cell lysates were analyzed for caspase-3, -8, and -9 activi-
ties. The native WNV-Cp constructs showed strong caspase-3
activity (Figure 5c). In addition, this 3′ -deletion mutant
showed similarly lower induction of caspase-9 activity (Figure
5d). These data support the hypothesis that this 3′  domain
plays an important role in the induction of apoptosis by the
WNV-Cp protein. Furthermore, to confirm that this apoptosis-
induction pathway is through caspase-9, a domant negative
(DN) caspase-9 construct, which has been reported to inhibit
the caspase cascade, was cotransfected wiwth pcWNV-Cp-
DJY or pcWNV-CpWT and the expression level of pro-
caspase-9 cleavage products (35–37 kDa) was compared to the
Figure 2. West Nile virus capsid (WNV-cp)-DJY protein expression
induces apoptosis. Nuclear condensation was observed in HeLa cells
transfected with pcWNV-Cp-DJY (a), a positive control pBax (b), or a
negative control, pcDNA3.1 (c), under a 4,6-diamidino-2-phenylidole
(DAPI) filter (magnification: 200X). Light microscopic observation on
pcWNV-Cp-DJY (d) or pcDNA3.1 (e) plasmid transfected RD cells were
examined in semithin sections stained with toluidine blue (magnifica-
tion for d and e: 400X). Ultramicroscopic image of apoptotic cells were
photographed from pcWNV-Cp-DJY transfected RD cells (f). DNA frag-
mentation in WNV capsid–expressing cell lines was examined by termi-
nal desoxyriboxyl-desoxyriboxyl trasferase–mediated DVTP nick-end
labeling (TUNEL) assay in HeLa (g), HEK 293 (i), and RD cells (k), and
compared with DNA fragmentation from pcDNA3.1-transfected HeLa
cells (m). Nuclear staining in HeLa (h), HEK 293 (j), and RD cells (l)
were observed by using a DAPI filter and compared with control HeLa
cells (n) (magnification for g through n: 400X). Cell membrane morphol-
ogy changes were examined by annexin V staining/flow cytometry by
using HeLa cells transfected with pcWNV-Cp-DJY or control pcDNA3.1
plasmids (o). The human neuroblastoma cell line SH-SY5Y was trans-
fected with Bax as a positive control (p), pcWNV-Cp (r), or control plas-
mid (t) and examined by TUNEL assay. To visualize nuclear staining,
cells transfected with pBax, pcWNV-Cp-DJY (q and s, respectively) or
pcDNA3.1 (u) were stained with DAPI and observed using appropriate
filters (magnification: 400X).Emerging Infectious Diseases  •  Vol. 8, No. 12, December 2002 1383
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activity of the 3′ -deletion mutant, pcWNV-Cp∆ 3′  and
pcDNA3.1 in Western blot analysis. The DN caspase-9 specif-
ically blocked the cleavage of pro-caspase-9 in pcWNV-Cp-
DJY and pcWNV-CpWT cotransfected cell lysates compared
to those of pcWNV-Cp-DJY or pcWNV-CpWT in transfected
cell lysates (Figure 5e). Moreover, the cell lysate transfected
with the 3′ -terminal deletion mutant had lower cleavage of
pro-caspase-9, which is related to the lower induction of
caspase-3 and –9 activity as determined by protease activity
assay (Figure 5c,d). Cell lysates from pcDNA3.1 control trans-
fected cells show much less pro-caspase-9 cleavage products.
Although the apoptotic effects of wild-type WNV as well
as other flaviviruses have been previously reported, the gene
or genes responsible for this effect in WNV have not been
described. The Cp-induced apoptosis in the brain implies that
the expression of the WNV-Cp protein in the central nervous
system may play an important role in initiating neuronal cell
death through apoptosis-induced inflammation. Therefore, this
process may be important in the pathogenesis of WNV-
induced encephalitis. 
In this study, the WNV-Cp protein–induced apoptosis
through the destabilization of the mitochondrial transmem-
brane, resulting in the likely release of cytochrome c (20,21).
The complex of cytochrome c/Apaf-1 recruits and activates
procaspase-9 (22), not procaspase-8. Paradoxically, the karyo-
philicity of WNV-Cp protein does not fully explain the desta-
bilization of the mitochondrial membrane and its ability to
drive the caspase-9 apoptotic pathway. Therefore, it is possible
that WNV-Cp changes the host cell transcriptional machinery,
resulting in an over expression of certain proteins related to an
apoptotic program, which consequently feed back to the mito-
chondria, or that as WNV-Cp moves from the cytoplasm to the
nucleus, it may sequester or inactivate an important member of
the antiapoptotic pathway or the cell cycle pathway, and thus
induce the apoptotic cascade. Furthermore, the data suggest
that WNV-Cp may interact with host cell proteins to induce
apoptosis in the host cell. Identifying these proteins will likely
give more insight into the biology of WNV. This biology likely
involves the WNV-Cp 3′  region. Moreover, this flavivirus con-
tains a capsid protein, which localizes to the nucleus. Flavivi-
rus replication is normally cytoplasmic, although some
evidence supports nuclear function as part of the viral life
cycle. In fact, Kunjin virus capsid has been found in the
nucleus (23). Our results identify the nuclear localizing prop-
erty of the protein as a potential pathogenic attribute. Hence,
the pathogenic region of the protein is localized within the 3′ -
terminal region. Therefore, creating a WNV isolate that no
longer localizes the capsid to the nucleus may result in a virus
that loses pathogenesis, providing a novel approach for
Figure 3. In vivo West Nile virus capsid expression induces apoptosis
and inflammation in mice. TUNEL assay was performed on muscle cry-
osections harvested from mice injected with pcWNVCp-DJY (a) or
pcDNA3.1 (b). Hematoxylin/eosin staining was performed on mouse tib-
ialis muscle cryosections harvested from mice injected with pcWNVCp-
DJY (c) or pcDNA3.1 (d) at 48 h postinjection (magnification: 200X [a,
b] and 40X [c, d]). Immunohistochemical analysis was performed for
detection of WNVCp-DJY protein expression in mouse brain injected
with pcDNA3.1 or pcWNVCp-DJY as detected with HRP [Q17: spell
out?](e, f, respectively). TUNEL assay on mouse brain cryosections
harvested from pcWNVCp-DJY injected mouse was detected with HRP
(g) (magnification: 300X [e through g]). Immunohistochemical studies
were performed for detection of WNVCp-DJY protein expression in
mouse brain injected with pcWNVCp-DJY or pcDNA3.1 as detected by
fluorescein isothiocynate stain (h, i, and j , k, respectively). TUNEL
assay on mouse brain cryosections harvested from pcWNVCp-DJY–
injected mice (l, m) or pcDNA3.1-injected mice as detected with fluores-
cein isothiocyanate (n, o). WNVCp-DJY protein expressing His-positive
cells or TUNEL-positive cells were visualized under ultraviolete micro-
scope (h or l, respectively). Nuclear staining for WNVCp-DJY– or
pcNDA3.1-transfected cells was visualized with appropriate filters (i, m
or k, o, respectively) (magnification: 630X [h through o]).
Figure 4. Mitochondria transmembrane potential and caspase activities
measurement. HeLa-CD4 cells were transfected with pcWNVCp-DJY (a)
or pcDNA3.1 (b), and their mitochondria transmembrane potential was
measured after 48 h by ultraviolete illumination. A colorimetric caspase
activity assay was performed with pcWNVCp-DJY– or pcDNA3.1-trans-
fected cells for caspase-3 (c) or caspase-9 (d) activity. As a specificity
control, the inhibitor LEHD-FMK for caspase-9 was added to the reac-
tions along with relevant substrate (d). A specific positive control was
used for assay validation (magnification: 1000X [a and b]).RESEARCH
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vaccine studies. These results also imply that inhibiting the C-
terminal region’s ability to interact with its putative ligand
could be an important target for the development of new treat-
ments for WNV infection.
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Figure 5. Apoptosis determining domain in WNVCp gene. a, Schematic
diagram of pcWNVCp-DJY, pcWNVCpWT and pcWNVCp_3’ con-
structs. b, Immunoprecipitation of in vitro translated protein from pcWN-
VCp-DJY (Cp-DJY), pcWNVCpWT (CpWT), and pcWNVCp-3’ (Cp_3’)
plasmids. As a negative control, pcDNA3.1 in vitro translated superna-
tants were analyzed. c, Colorimetric caspase-3 activity assay using
pcWNVCp-DJY (Cp-DJY), pcWNVCpWT (CpWT), or pcWNVCpD3′
(CpD3’) plasmid transfected cells. d, The cell lysates were assayed for
caspase-9-like activity, and the pcDNA3.1 transfected cell lysate was
used as the negative control. e, Inhibition of WNVCp induced apoptosis
by a dominant negative (DN) caspase-9 plasmid (DN Casp9) was
assayed with equal amount of cell lysates from co-transfection of
pcWNVCp-DJY (Cp-DJY) or pcWNVCpWT (CpWT), an expression
level of pro-caspase-9 cleavage products (35 to 37 kDa) was compared
to 3′ -terminal deletion mutant, pcWNVCp_3’ (Cp_3′ ) and pcDNA3.1 by
Western blot analysis with anti-human caspase-9 mAb.